The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

• Päätekijät: Mirela Costa de Miranda (Tekijä), Luciana Bertocco de Paiva Haddad (Tekijä), Evelinda Trindade (Tekijä), Alex Cassenote (Tekijä), Giselle Y. Hayashi (Tekijä), Durval Damiani (Tekijä), Fernanda Cavalieri Costa (Tekijä), Guiomar Madureira (Tekijä), Berenice Bilharinho de Mendonca (Tekijä), Tania A. S. S. Bachega (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Newborn screening for congenital adrenal hyperplasia (CAH-NBS) is not yet a worldwide consensus, in part due to inconclusive evidence regarding cost-effectiveness because the analysis requires an understanding of the short- and long-term costs of care associated with delayed diagnosis.Ob...